Literature DB >> 18988929

Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.

Jong-Han Lee1, Woonhyung Lee, Oh Hun Kwon, Jeong-Ho Kim, Oh Woong Kwon, Kyung Hwan Kim, Jong-Baeck Lim.   

Abstract

To evaluate the usefulness of cytokine levels of peripheral blood in diabetic retinopathy (DR), demographic and biochemical parameters including low-density lipoprotein (LDL) diameter as well as cytokine profiles were analyzed in 74 patients with type 2 diabetes mellitus (DM), with DR (n=46) or without DR (n=28). DM duration was longer in the patients with DR than without (p<0.001). Serum glucose (p=0.005) and total cholesterol (p=0.029) levels were higher in DM patients with DR than DM patients without DR. Plasma LDL diameter, interleukin-6 (IL-6), and interleukin-8 (IL-8) showed significant differences among the different degrees of DR severity in analysis of variance (ANOVA) with no definite trend. The risk of DR in DM patients was decreased by an increase of interleukin-10 (IL-10) level [odds ratio (OR)=0.152; confidence interval (CI): 0.028-0.817]. Plasma LDL diameter was smaller and IL-6 and tumor necrosis factor-alpha (TNF-alpha) levels were higher in DM patients with proliferative diabetic retinopathy (PDR) compared to those with non-proliferative diabetic retinopathy (NPDR) (p<0.05). We found that higher IL-10 levels were related to lower risk of DR in DM patients. Levels of IL-6 and TNF-alpha as well as LDL diameter may be helpful in the prediction of PDR in DM patients with DR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988929

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  22 in total

Review 1.  The pathogenesis of early retinal changes of diabetic retinopathy.

Authors:  G B Arden; S Sivaprasad
Journal:  Doc Ophthalmol       Date:  2012-02       Impact factor: 2.379

2.  Comparison of inflammatory cytokines levels in the aqueous humor with diabetic retinopathy.

Authors:  Haijiang Zhang; Liang Liang; Rong Huang; Ping Wu; Liye He
Journal:  Int Ophthalmol       Date:  2020-06-15       Impact factor: 2.031

3.  New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.

Authors:  Viktor R Drel; Sergey Lupachyk; Hanna Shevalye; Igor Vareniuk; Weizheng Xu; Jie Zhang; Nicholas A Delamere; Mohammad Shahidullah; Barbara Slusher; Irina G Obrosova
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

4.  Transplantation of IL-10-transfected endothelial progenitor cells improves retinal vascular repair via suppressing inflammation in diabetic rats.

Authors:  Ying Wang; Lingling Fan; Xiangda Meng; Feng Jiang; Qingzhong Chen; Zhuhong Zhang; Hua Yan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-12       Impact factor: 3.117

5.  Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss.

Authors:  Naiomy D Rios-Arce; Andrew Dagenais; Derrick Feenstra; Brandon Coughlin; Ho Jun Kang; Susanne Mohr; Laura R McCabe; Narayanan Parameswaran
Journal:  J Cell Physiol       Date:  2019-09-19       Impact factor: 6.384

6.  Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.

Authors:  Marc Figueras-Roca; Jessica Matas; Víctor Llorens; Anna Sala-Puigdollers; Manuel Navarro; Javier Zarranz-Ventura; Alfredo Adán; Blanca Molins
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-12       Impact factor: 3.117

7.  Increased vitreal levels of interleukin-10 in diabetic retinopathy: a Meta-analysis.

Authors:  Wei Tan; Jing-Ling Zou; Shigeo Yoshida; Bing Jiang; Ye-Di Zhou
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

8.  High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes.

Authors:  Yolanda Gonzalez; M Teresa Herrera; Gloria Soldevila; Lourdes Garcia-Garcia; Guadalupe Fabián; E Martha Pérez-Armendariz; Karen Bobadilla; Silvia Guzmán-Beltrán; Eduardo Sada; Martha Torres
Journal:  BMC Immunol       Date:  2012-04-14       Impact factor: 3.615

9.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

10.  Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators.

Authors:  Claudio Blasi; Eunjung Kim; Anne A Knowlton
Journal:  Autoimmune Dis       Date:  2012-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.